Low Dose Naltrexone as an adjunct to Cancer Therapy
It has been a bit more than 2 weeks since I have been given the all clear after more than 200 days of treatments and activities to treat my SCC cancer. I was told by both my G.P and radiologist that I am in remission after a PET Scan was unable to find any cancer in my body and confirming that this was also the case with the lymph node in the left side of my neck where the tumour was located.
A couple of weeks earlier I got the results back from what is called a CTC Oncotrace Test. This measures the circulating tumour cells in the blood as well as the cancer stem cells. When I had my first test in January 2021 the reading was 3.2, as of late June it was 2.7 which is a drop of about 15%. I was hoping for more but according to Dr Eng (my G.P) that was a pretty good result and showed that I was on the way to being in a relatively safe position.
Dr Eng has given me a target of a reading of 2 or less. This will put me in a really safe place and if I maintain my body in a state of good health the cancer should stay at bay.
I decided that another 10 week treatment of IV Vitamin C, Quercitin and Curcumin plus 3 hours of HBOT a week would be a worthwhile investment both time wise and financially to help achieve this goal.
Dr Eng recently mentioned a medicine called low dose naltrexone (LDN). He gave me some medical studies to review so I could make a decision about whether I would be interested in using this to potentially lower the CTCs (circulating tumour cells). I looked at the data and decided that I would give it a go and then take a break from everything at the end of August when I will go off all treatment for 7 days and then do another Oncotrace test.
What is LDN?
Naltrexone (NTX) is an opioid antagonist traditionally used for alcohol and opioid disorders, but various studies have documented its involvement in cancer progression, exploring possible anticancer potential when administered as low dose naldextrone (1.5-4.5 mg tablets).
Cancer is a condition in which cells within the body divide at an uncontrolled rate. Our body’s natural defence against these cells are known as tumour suppressor genes. Mutations can occur, leading to the formation of oncogenes that promote cell growth and reproduction, or suppression of tumour suppressor genes. This can cause proliferation. These cancerous cells can then travel to other parts of the body through the bloodstream. This is called metastasis.
When used in low doses naltrexone is known to act as an anti-inflammatory. LDN can cause increased cell death in certain cancers.
Dr Bernard Bihari M.D (1931-2010) was the discoverer of the clinical effects of LDN in humans. One of the things he discovered was that naltrexone increased the endorphin production in the body. Amongst other things endorphins can boost the immune system so that the immune cells (white blood cells – T-lymphocytes) double very quickly and the immune functions all improve.
People with cancer are generally found to have low endorphin levels, generally less than 30% of normal. Endorphins are also thought to increase natural killer cells which can help the body fight against cancer.
You should talk to your GP and oncologist about LDN but do as much of your own research as you possibly can before bring it up. There are a couple of links in this post as well as a YouTube clip but there is a lot more data available.
So for me it’s a no brainer. Naltrexone has been around since the early 1980s and the side effects appear to be minimal. It is inexpensive and readily available and even though more clinical testing needs to be done there is an apparency that low doses have significantly helped many people fight cancer and even kill cancer cells.
That is my reason for using this medicine. If there is any chance at all that it can help kill any small cancer cells in my body then I can’t see what harm it can do to use it.
The proof will be in the pudding and will hopefully help with good results in the Oncotrace test I will have in the next 2 months.
